---
name: I3.5 Management of Histologic HSIL and CIN2 Remains Present for a 2-year Period in Those Who Are Concerned About the Potential Effect of Treatment on Future Pregnancy Outcomes 

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1991-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
- 
  $iterate: *UnspecifiedHSILorCIN2TwoYearsAgo
-
  $iterate: *UnspecifiedHSILorCIN2ThisYear
- 
  resourceType: Observation
  code: http://OUR-PLACEHOLDER-URL.com#FPCQ Does the patient have future pregnancy concerns related to treatment options?
  status: final
  valueCodeableConcept: SNOMEDCT#373066001 Yes (qualifier value)
  effectiveDateTime: 2021-05-01

results:
  Recommendation:
    short: 'Surveillance or Treatment'
    date: '2021-06-02'
    group: 'Managing Histology (I.3)'
    details: 
      - 'Treatment is recommended for CIN2 lasting 2 years.'
      - 'Excisional treatment is preferred, and treatment with ablation is acceptable.'
      - 'When considering ablative therapy, in particular cryotherapy, ablation is unacceptable in circumstances defined by the WHO.'
